SGLT2 inhibitors in clinical practice
- PMID: 38768619
- DOI: 10.1016/S2213-8587(24)00133-5
SGLT2 inhibitors in clinical practice
Conflict of interest statement
We declare no competing interests.
Comment on
-
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis.Lancet Diabetes Endocrinol. 2024 Jul;12(7):447-461. doi: 10.1016/S2213-8587(24)00102-5. Epub 2024 May 17. Lancet Diabetes Endocrinol. 2024. PMID: 38768620
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
